Genuine Arishta contains only self-generated alcohol from natural fermentation. Visual inspection cannot detect adulteration.
Genuine Arishta contains only self-generated alcohol produced through controlled natural fermentation, not externally sourced spirit added after processing. Visual inspection cannot detect adulteration. Chemical testing, batch record review and a clear understanding of what the pharmacopoeia specifies are the reliable verification tools available to any buyer assessing a new supplier or an incoming consignment.
The Ayurvedic Formulary of India and the Drugs and Cosmetics Act both require that the alcohol in Arishta preparations arise entirely from natural fermentation of sugars by microorganisms, typically from Dhataki or Madhuka flowers added to the prepared kasaya. No spirit, ethanol or alcohol from any external source may be added at any point during manufacture.
The regulatory rationale is straightforward: self-generated alcohol is produced gradually alongside the extraction of phytochemicals from the herb mixture, resulting in a product with a specific compositional profile. Externally added alcohol, while it may produce a liquid with a similar alcohol reading, does not replicate this extraction process and produces a fundamentally different product that cannot meet the total solids, pH and other pharmacopoeial parameters specified for a genuine Arishta.
For buyers operating in regulated markets, accepting adulterated product and placing it on sale as a classical Arishta preparation is a regulatory offence under the Drugs and Cosmetics Act. The liability rests not only with the manufacturer but with any party in the supply chain who knowingly or negligently facilitates the sale of a misbranded preparation.
Several analytical approaches are used to assess whether an Arishta is genuine. The most commonly applied tests in routine pharmacopoeial compliance include alcohol by volume, total solids, pH, specific gravity, and methanol testing. Taken together, these parameters provide a composite picture of the product's authenticity.
Alcohol by volume alone does not distinguish self-generated from added alcohol. However, the ratio of alcohol to total solids is a useful screening indicator. Genuine Arishta with properly completed fermentation will have a total solids level consistent with the pharmacopoeial specification. A product with alcohol content at specification but unusually low total solids is a potential flag for added alcohol with insufficient plant extraction.
Methanol testing is a separate but related quality point. Methanol can appear in fermented products if raw materials are contaminated or fermentation is poorly controlled. Its presence is a disqualifying finding. Some laboratories also offer isotope ratio analysis to differentiate the source of ethanol, though this is more commonly used in premium or export compliance contexts than in routine domestic trade.
HPTLC fingerprinting of the finished product, compared to a reference chromatogram for the specific formula, provides a further layer of authenticity verification by confirming that the expected phytochemical markers from the named herbs are present at expected levels.
A COA for a genuine Arishta should declare tested values for all pharmacopoeial parameters with the corresponding specification ranges drawn from the AFI monograph for that formula. A COA that lists only some parameters, or that provides ranges without tested values, is incomplete and should not be accepted as verification of quality.
The COA should identify the batch number, manufacturing date, expiry date and the specific formula name. It should be issued by a laboratory whose methods can be verified, either an accredited in-house laboratory or an independent NABL-accredited testing facility. The COA should be signed by a qualified analytical professional.
Buyers sourcing Asava-Arishta at volume should request COAs for at least two or three consecutive production batches when qualifying a new supplier. Consistency across batches is evidence of controlled production. Significant variation between batches of the same formula is a warning sign that process control is inadequate, regardless of whether individual batches pass specification.
Several patterns in supplier behaviour or product documentation should prompt caution. A manufacturer who is reluctant to provide batch manufacturing records or who claims that records are proprietary and cannot be shared is not operating in compliance with Schedule T, which requires transparency to inspecting authorities and, implicitly, to buyers conducting legitimate due diligence.
Pricing that appears significantly below market norms for a named classical preparation is another warning sign. Genuine Arishta requires quality raw materials, a controlled kasaya preparation, a documented fermentation hold period and comprehensive testing. Preparations offered at prices that cannot support this process are unlikely to be produced to the required standard.
Inconsistent labelling, including the absence of the manufacturer's AYUSH licence number, missing batch numbers or expiry dates, or an address that cannot be verified against licence records, should all trigger enquiry before a purchase commitment is made. For contract manufacturing relationships, request a copy of the AYUSH licence and verify the licence number against the relevant state drug authority's published records.
GMP certification under Schedule T does not by itself guarantee that a specific batch is genuine, but it establishes the quality management framework within which genuine product is most reliably produced. A GMP-certified manufacturer is required to maintain batch manufacturing records, conduct in-process checks, test finished product before release and retain records for an auditable period.
For buyers, GMP certification is a baseline requirement rather than a complete quality assurance solution. It should be supplemented by COA review for every batch, periodic third-party testing for high-value or export orders, and an initial supplier audit where the relationship is of significant commercial scale.
Raasa Ayurveda holds GMP certificate D-5755/09 and AYUSH manufacturing licence A-4177/2009 for its Kanpur facility, covering 37 formulations in the Asava-Arishta category. A certificate of analysis accompanies every consignment, and samples are available for buyer testing before bulk orders are confirmed.
A single satisfactory COA at the start of a supply relationship does not guarantee that subsequent batches will meet the same standard. Ongoing quality monitoring should include COA review for every batch, with the buyer comparing declared values against specification rather than simply filing the document. Any parameter that trends toward a specification limit over successive batches should trigger a formal enquiry.
For large or long-term bulk supply relationships, a periodic audit of the manufacturer's facility is reasonable practice. The audit need not be adversarial; a manufacturer confident in its GMP compliance will welcome a structured visit by a buyer's quality team as an opportunity to demonstrate process control and build trust.
To discuss quality documentation, COA formats or the verification process for Arishta preparations, contact Raasa Ayurveda in Kanpur at raasaayurveda@gmail.com or call +91 9415128217. We are available to discuss sample provision and documentation requirements before any commitment is made.
Routine pharmacopoeial tests cannot definitively distinguish self-generated from added alcohol in isolation, but the combination of alcohol content, total solids, pH and specific gravity provides a composite picture. A genuine Arishta will have total solids consistent with full plant extraction. Isotope ratio analysis can provide a more definitive result and is used in export compliance contexts.
A complete COA should declare tested values alongside AFI specification ranges for alcohol by volume, total solids, specific gravity, pH, methanol absence, microbial limit results, heavy metal screen and ash value. It should identify the batch number, manufacturing and expiry dates, and be signed by a qualified analyst. A COA covering only some parameters should not be accepted.
GMP certification establishes the quality management framework required for genuine product to be reliably produced, but it does not guarantee any individual batch. Buyers should supplement GMP verification with COA review for every batch and periodic third-party testing for high-value orders. GMP is a necessary starting point, not a complete quality assurance substitute for ongoing documentation review.
Under the Drugs and Cosmetics Act, selling a misbranded or adulterated Ayurvedic preparation is an offence that can result in product seizure, licence suspension and prosecution. Liability can extend beyond the manufacturer to distributors or brand owners who place adulterated product in the market. Independent batch testing and robust COA review are the buyer's primary protections.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.